» Articles » PMID: 10744022

Translation Termination in Eukaryotes: Polypeptide Release Factor ERF1 is Composed of Functionally and Structurally Distinct Domains

Overview
Journal RNA
Specialty Molecular Biology
Date 2000 Apr 1
PMID 10744022
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Class-1 polypeptide chain release factors (RFs) trigger hydrolysis of peptidyl-tRNA at the ribosomal peptidyl transferase center mediated by one of the three termination codons. In eukaryotes, apart from catalyzing the translation termination reaction, eRF1 binds to and activates another factor, eRF3, which is a ribosome-dependent and eRF1-dependent GTPase. Because peptidyl-tRNA hydrolysis and GTP hydrolysis could be uncoupled in vitro, we suggest that the two main functions of eRF1 are associated with different domains of the eRF1 protein. We show here by deletion analysis that human eRF1 is composed of two physically separated and functionally distinct domains. The "core" domain is fully competent in ribosome binding and termination-codon-dependent peptidyl-tRNA hydrolysis, and encompasses the N-terminal and middle parts of the polypeptide chain. The C-terminal one-third of eRF1 binds to eRF3 in vivo in the absence of the core domain, but both domains are required to activate eRF3 GTPase in the ribosome. The calculated isoelectric points of the core and C domains are 9.74 and 4.23, respectively. This highly uneven charge distribution between the two domains implies that electrostatic interdomain interaction may affect the eRF1 binding to the ribosome and eRF3, its activity in the termination reaction and activation of eRF3 GTPase. The positively charged core of eRF1 may interact with negatively charged rRNA and peptidyl-tRNA phosphate backbones at the ribosomal eRF1 binding site and exhibit RNA-binding ability. The structural and functional dissimilarity of the core and eRF3-binding domains implies that evolutionarily eRF1 originated as a product of gene fusion.

Citing Articles

Functional Activity of Isoform 2 of Human eRF1.

Shuvalov A, Klishin A, Biziaev N, Shuvalova E, Alkalaeva E Int J Mol Sci. 2024; 25(14).

PMID: 39063238 PMC: 11277123. DOI: 10.3390/ijms25147997.


Therapeutic Nonsense Suppression Modalities: From Small Molecules to Nucleic Acid-Based Approaches.

Morais P, Zhang R, Yu Y Biomedicines. 2024; 12(6).

PMID: 38927491 PMC: 11201248. DOI: 10.3390/biomedicines12061284.


The space between notes: emerging roles for translationally silent ribosomes.

Smith P, Pandit S, Loerch S, Campbell Z Trends Biochem Sci. 2022; 47(6):477-491.

PMID: 35246374 PMC: 9106873. DOI: 10.1016/j.tibs.2022.02.003.


Two alternative conformations of mRNA in the human ribosome during elongation and termination of translation as revealed by EPR spectroscopy.

Bulygin K, Timofeev I, Malygin A, Graifer D, Meschaninova M, Venyaminova A Comput Struct Biotechnol J. 2021; 19:4702-4710.

PMID: 34504663 PMC: 8390954. DOI: 10.1016/j.csbj.2021.08.024.


Termi-Luc: a versatile assay to monitor full-protein release from ribosomes.

Susorov D, Egri S, Korostelev A RNA. 2020; 26(12):2044-2050.

PMID: 32817446 PMC: 7668252. DOI: 10.1261/rna.076588.120.


References
1.
Tate W, Brown C . Translational termination: "stop" for protein synthesis or "pause" for regulation of gene expression. Biochemistry. 1992; 31(9):2443-50. DOI: 10.1021/bi00124a001. View

2.
Ebihara K, Nakamura Y . C-terminal interaction of translational release factors eRF1 and eRF3 of fission yeast: G-domain uncoupled binding and the role of conserved amino acids. RNA. 1999; 5(6):739-50. PMC: 1369801. DOI: 10.1017/s135583829998216x. View

3.
Grentzmann G, Heurgue V, Mora L, Buckingham R . Localization and characterization of the gene encoding release factor RF3 in Escherichia coli. Proc Natl Acad Sci U S A. 1994; 91(13):5848-52. PMC: 44094. DOI: 10.1073/pnas.91.13.5848. View

4.
Moffat J, Tate W . A single proteolytic cleavage in release factor 2 stabilizes ribosome binding and abolishes peptidyl-tRNA hydrolysis activity. J Biol Chem. 1994; 269(29):18899-903. View

5.
Brown C, Tate W . Direct recognition of mRNA stop signals by Escherichia coli polypeptide chain release factor two. J Biol Chem. 1994; 269(52):33164-70. View